Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 2 (MTND1P2) is a pseudogene related to the mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 (MT-ND1) gene. MTND1P2 does not encode a functional protein; instead, it represents a non-functional genomic sequence that arose by duplication or retrotransposition from the active MT-ND1 gene. Unlike MT-ND1, which encodes a core subunit of mitochondrial respiratory chain complex I with critical roles in oxidative phosphorylation, energy production, and disease, MTND1P2 lacks coding and biological function and is not implicated as a drug target, disease biomarker, or therapeutic entity[1][2][3][4]. Additional clarification: There appears to be a misunderstanding in treating MT-ND1 pseudogene 2 (MTND1P2) as a molecular target. It is a pseudogene—not an active gene, receptor, enzyme, transporter, or therapeutic target. The functional and disease-related information found in the search results pertains to the protein-coding MT-ND1 gene, not MTND1P2, which remains noncoding and without known biological or clinical roles[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 2 (MTND1P2).